Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged
in late 2019 and spread globally, prompting an international effort to accelerate development …

Background Streptococcus pneumoniae is the chief cause of pneumonia in older adults, but
it remains unclear whether use of the pneumococcal polysaccharide vaccine alters the …

Background Streptococcus pneumoniae is a major cause of morbidity and mortality among
adults 50 years of age and older in the United States. Pneumococcal conjugate vaccines are …

Men and women differ in their response to cocaine, and a woman's response varies with the
menstrual cycle. For example, women have greater subjective responses to cocaine in the …

Background The currently recommended single dose of the 23-valent pneumococcal free
polysaccharide vaccine (PPSV23) for adults 65 years of age and older does not provide …

ContextRevaccination of healthy adults with pneumococcal polysaccharide vaccine (PPV)
within several years of first vaccination has been associated with a higher than expected …

Objective: To determine risk factors for community-acquired and nosocomial group B
streptococcal disease in adults. Design: Case-control study. Setting: 3 metropolitan areas in the …

Banked acute-phase and convalescent-phase serum samples from a previous study of
respiratory illness in university students were examined for significant (≥2-fold) increases in …

Background . Pneumonia is recognized as a leading cause of morbidity in seniors. However,
the overall burden of this disease—and, in particular, the contribution of ambulatory cases …

Chlamydia pneumoniae has been associated with atherosclerotic cardiovascular disease
by both seroepidemiologic studies and direct detection of the organism in atherosclerotic …